This study assessed the changes in mRNA expression (Figure 4A) and protein levels (Figure 4B,C) of inflammatory factors (NLRP3, ASC, Caspase-1, and IL-1β) in various groups in order to determine whether APS affects the NLRP3 pathway (with decreased expression) and ultimately lessens the degree of cellular EMT. This evidence concerns the gene IL1B and autoimmune polyendocrinopathy.